115 related articles for article (PubMed ID: 21420870)
1. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention.
Wittig A; Stecher-Rasmussen F; Hilger RA; Rassow J; Mauri P; Sauerwein W
Appl Radiat Isot; 2011 Dec; 69(12):1760-4. PubMed ID: 21420870
[TBL] [Abstract][Full Text] [Related]
2. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
[TBL] [Abstract][Full Text] [Related]
4. Cell type selective accumulation of mercaptoundecahydro- closo-dodecaborate (BSH) in glioblastoma multiforme.
Neumann M; Bergmann M; Gabel D
Acta Neurochir (Wien); 2003 Nov; 145(11):971-5. PubMed ID: 14628202
[TBL] [Abstract][Full Text] [Related]
5. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
6. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
[TBL] [Abstract][Full Text] [Related]
7. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
8. Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat.
Morris GM; Constantine G; Ross G; Yeung TK; Hopewell JW
Radiat Res; 1993 Sep; 135(3):380-6. PubMed ID: 8378531
[TBL] [Abstract][Full Text] [Related]
9. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy.
Neumann M; Kunz U; Lehmann H; Gabel D
J Neurooncol; 2002 Apr; 57(2):97-104. PubMed ID: 12125978
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
11. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 10B in the central degenerative areas of human glioma and colon carcinoma spheroids after sulfhydryl boron hydride administration.
Pettersson OA; Carlsson J; Grusell E
Cancer Res; 1992 Mar; 52(6):1587-91. PubMed ID: 1540968
[TBL] [Abstract][Full Text] [Related]
13. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
[TBL] [Abstract][Full Text] [Related]
14. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
[TBL] [Abstract][Full Text] [Related]
17. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy.
Mehta SC; Lai JC; Lu DR
J Microencapsul; 1996; 13(3):269-79. PubMed ID: 8860683
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
[TBL] [Abstract][Full Text] [Related]
20. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]